Aldatu Biosciences Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Aldatu Biosciences advances the development of innovative diagnostic tools that drive our collective response to global health emergencies. Aldatu’s proprietary PANDAA technology is a qPCR-enabling platform that overcomes long-standing diagnostic challenges to enhance the quality and affordability of high-throughput infectious disease diagnostics and improve patient access to diagnostics in resource-limited countries. Our PANDAA qDx™ SARS-CoV-2 assay is being implemented in numerous clinical labs and we have established Aldatu Diagnostics, a clinical lab dedicated to supporting our community’s needs for COVID-19 testing using Aldatu Biosciences’ PANDAA technology.